for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Norway drops AstraZeneca vaccine, J&J remains on hold

OSLO, May 12 (Reuters) - Norway will not resume the use of COVID-19 vaccines made by AstraZeneca, while a decision on whether to start using inoculations made by Johnson & Johnson’s remains on hold, Prime Minister Erna Solberg said on Wednesday.

A government-appointed commission had recommended that both vaccines should be excluded from Norway’s vaccination programme due to a risk of rare but harmful side-effects. (Reporting by Terje Solsvik, editing by Nerijus Adomaitis)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up